Revvity (RVTY) EBT Margin Growth (1y) (2010 - 2026)
Revvity (RVTY) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -37.00 |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -85.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -85.00 |
| Dec 28, 2025 | -111.00 |
| Sep 28, 2025 | -670.00 |
| Jun 29, 2025 | -300.00 |
| Mar 30, 2025 | 256.00 |
| Sep 29, 2024 | 713.00 |
| Jun 30, 2024 | 244.00 |
| Mar 31, 2024 | 95.00 |
| Oct 1, 2023 | -400.00 |
| Jul 2, 2023 | -1,295.00 |
| Apr 2, 2023 | -1,899.00 |
| Jan 1, 2023 | -1,048.00 |
| Oct 2, 2022 | -414.00 |
| Jul 3, 2022 | -1,005.00 |
| Apr 3, 2022 | -2,214.00 |
| Jan 2, 2022 | -577.00 |
| Oct 3, 2021 | -857.00 |
| Jul 4, 2021 | 1,278.00 |
| Apr 4, 2021 | 4,017.00 |
| Jan 3, 2021 | 2,682.00 |